Highline Capital Management, L.P. Ginkgo Bioworks Holdings, Inc. Transaction History
Highline Capital Management, L.P.
- $0
- Q4 2022
Shares
2 transactions
Others Institutions Holding DNA
# of Institutions
256Shares Held
888MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.09 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.06 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$1.02 Billion0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$532 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$320 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $9.81B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...